185 related articles for article (PubMed ID: 20709004)
1. Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity.
Hu B; Dai B; Wang P
Vaccine; 2010 Sep; 28(41):6675-83. PubMed ID: 20709004
[TBL] [Abstract][Full Text] [Related]
2. Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity.
Hu B; Yang H; Dai B; Tai A; Wang P
Hum Gene Ther; 2009 Dec; 20(12):1652-64. PubMed ID: 19663564
[TBL] [Abstract][Full Text] [Related]
3. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
He Y; Zhang J; Mi Z; Robbins P; Falo LD
J Immunol; 2005 Mar; 174(6):3808-17. PubMed ID: 15749922
[TBL] [Abstract][Full Text] [Related]
4. Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy.
Odegard JM; Kelley-Clarke B; Tareen SU; Campbell DJ; Flynn PA; Nicolai CJ; Slough MM; Vin CD; McGowan PJ; Nelson LT; Ter Meulen J; Dubensky TW; Robbins SH
J Immunother; 2015; 38(2):41-53. PubMed ID: 25658613
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth.
Bryson PD; Han X; Truong N; Wang P
Vaccine; 2017 Oct; 35(43):5842-5849. PubMed ID: 28916248
[TBL] [Abstract][Full Text] [Related]
6. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
[TBL] [Abstract][Full Text] [Related]
7. Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine.
Coutant F; Frenkiel MP; Despres P; Charneau P
PLoS One; 2008; 3(12):e3973. PubMed ID: 19096527
[TBL] [Abstract][Full Text] [Related]
8. Engineered lentivector targeting of dendritic cells for in vivo immunization.
Yang L; Yang H; Rideout K; Cho T; Joo KI; Ziegler L; Elliot A; Walls A; Yu D; Baltimore D; Wang P
Nat Biotechnol; 2008 Mar; 26(3):326-34. PubMed ID: 18297056
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
[TBL] [Abstract][Full Text] [Related]
10. Co-transfection gene delivery of dendritic cells induced effective lymph node targeting and anti-tumor vaccination.
Chen YZ; Ruan GX; Yao XL; Li LM; Hu Y; Tabata Y; Gao JQ
Pharm Res; 2013 Jun; 30(6):1502-12. PubMed ID: 23371516
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma.
Yang HG; Hu BL; Xiao L; Wang P
Cancer Gene Ther; 2011 May; 18(5):370-80. PubMed ID: 21372855
[TBL] [Abstract][Full Text] [Related]
12. Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines.
Negri DR; Rossi A; Blasi M; Michelini Z; Leone P; Chiantore MV; Baroncelli S; Perretta G; Cimarelli A; Klotman ME; Cara A
Retrovirology; 2012 Aug; 9():69. PubMed ID: 22913641
[TBL] [Abstract][Full Text] [Related]
13. Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy.
Morante V; Borghi M; Farina I; Michelini Z; Grasso F; Gallinaro A; Cecchetti S; Di Virgilio A; Canitano A; Pirillo MF; Bona R; Cara A; Negri D
Viruses; 2021 Feb; 13(2):. PubMed ID: 33672349
[TBL] [Abstract][Full Text] [Related]
14. Integrase Defective Lentiviral Vector Promoter Impacts Transgene Expression in Target Cells and Magnitude of Vector-Induced Immune Responses.
Mahesh S; Li J; Travieso T; Psaradelli D; Negri D; Klotman M; Cara A; Blasi M
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005931
[TBL] [Abstract][Full Text] [Related]
15. Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap.
Nabekura T; Otsu M; Nagasawa T; Nakauchi H; Onodera M
Mol Ther; 2006 Feb; 13(2):301-9. PubMed ID: 16311073
[TBL] [Abstract][Full Text] [Related]
16. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
Dullaers M; Thielemans K
J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
[TBL] [Abstract][Full Text] [Related]
17. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.
Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L
Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169
[TBL] [Abstract][Full Text] [Related]
18. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
19. Transient Expression of Green Fluorescent Protein in Integrase-Defective Lentiviral Vector-Transduced 293T Cell Line.
Nordin F; Hamid ZA; Chan L; Farzaneh F; Hamid MK
Methods Mol Biol; 2016; 1448():159-73. PubMed ID: 27317180
[TBL] [Abstract][Full Text] [Related]
20. A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model.
Gupta S; Termini JM; Rivas Y; Otero M; Raffa FN; Bhat V; Farooq A; Stone GW
Vaccine; 2015 Sep; 33(38):4798-806. PubMed ID: 26241951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]